Meropenem and Bacitracin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Meropenem (meropenem) and Bacitracin (bacitracin). Common drug interactions include dyspnoea among females and aspergillosis among males.
The phase IV clinical study analyzes what interactions people have when they take Meropenem and Bacitracin. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.
What is Meropenem?
Meropenem has active ingredients of meropenem. eHealthMe is studying from 33,295 Meropenem users. Check the latest studies of Meropenem.
What is Bacitracin?
Bacitracin has active ingredients of bacitracin. eHealthMe is studying from 1,214 Bacitracin users. Check the latest studies of Bacitracin.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
16 people who take Meropenem and Bacitracin together, and have interactions are studied.

What are the common drug interactions of Meropenem and Bacitracin, by gender? *:
female:
- Dyspnoea (difficult or laboured respiration)
- Encephalopathy (functioning of the brain is affected by some agent or condition)
- Endometrial cancer
- Endometrial hyperplasia (enlargement of uterus wall)
- Fatigue (feeling of tiredness)
- Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
- Fluid overload (too much fluid in the blood)
- Gastrointestinal necrosis (destruction of gastrointestinal organ)
- Haemothorax (collection of blood in the pleural space (the space between the lungs and the walls of the chest))
- Hyperbilirubinaemia (excess of bilirubin in the blood)
male:
- Aspergillosis (an infection caused by a fungus called aspergillus)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Depressed level of consciousness
- Diastolic dysfunction
- Drug toxicity
- Enterococcal infection
- Hypotension (abnormally low blood pressure)
- Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
- Immunosuppression
- Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
What are the common drug interactions of Meropenem and Bacitracin, by age (0-1 to 60+)? *:
0-1:
- Abdominal adhesions (inflammation of abdomen)
- Biliary cirrhosis (biliary cirrhosis occurs due to obstruction to the flow of bile through bile ducts either within the liver or outside the liver)
- Cerebral haematoma (collection of blood in brain)
- Cerebral haemorrhage (bleeding within the brain)
- Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
- Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
- Coagulopathy (blood's ability to clot is impaired)
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Hypersensitivity
- Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
2-9:
n/a
10-19:
n/a
20-29:
- Palpitations (feelings or sensations that your heart is pounding or racing)
- Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
- Polycystic ovaries (cysts in the ovaries that occurs when the follicle stops developing)
- Post procedural complication
- Presyncope
- Pulmonary hypertension (increase in blood pressure in the lung artery)
- Renal cancer (cancer of kidney)
- Renal failure acute (rapid kidney dysfunction)
- Respiratory distress (difficulty in breathing)
- Sepsis (a severe blood infection that can lead to organ failure and death)
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Abdominal pain upper
- Anaemia (lack of blood)
- Renal tubular necrosis (death of kidney tubules)
- Small intestinal obstruction (blockage in small intestine)
- Vomiting
- Weight decreased
- Cardiac arrest
- Coagulopathy (blood's ability to clot is impaired)
- Depressed level of consciousness
- Diastolic dysfunction
What are the existing conditions these people have? *
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 25.00%
- Staphylococcal Infection (an infection with staphylococcus bacteria): 3 people, 18.75%
- Sepsis (a severe blood infection that can lead to organ failure and death): 3 people, 18.75%
- Infection: 3 people, 18.75%
- Urinary Tract Infection: 1 person, 6.25%
- Splenic Abscess (pus in spleen or near by): 1 person, 6.25%
- Rash Vesicular (rash with a small bubble): 1 person, 6.25%
- Pain: 1 person, 6.25%
- Kidney Infection (Pyelonephritis): 1 person, 6.25%
- Conjunctivitis (pink eye): 1 person, 6.25%
* Approximation only. Some reports may have incomplete information.
Do you take Meropenem and Bacitracin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Meropenem (33,295 reports)
- Bacitracin (1,214 reports)
Browse all drug interactions of Meropenem and Bacitracin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Meropenem:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Bacitracin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Meropenem and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Bacitracin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .
- Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on meropenem and bacitracin (the active ingredients of Meropenem and Bacitracin, respectively), and Meropenem and Bacitracin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Tamsulosin Hydrochloride and Hypoglycaemia for Men aged 50-59 - a second ago
- Tamsulosin Hydrochloride and Low Blood Sugar for Men aged 50-59 - a second ago
- Tamsulosin Hydrochloride and Insulin Shock for Men aged 50-59 - a second ago
- Tamsulosin Hydrochloride and Hypoglycemia for Men aged 50-59 - a second ago
- Ulcerative Colitis and drugs of ingredients of hyaluronidase - 6 seconds ago
- Could Metronidazole cause Developmental Delay? - 10 seconds ago
- Cerebral Disorder and drugs of ingredients of docetaxel - 15 seconds ago
- Spironolactone and Coronary Artery Disease for Women aged 50-59 - 15 seconds ago
- Spironolactone and Chd for Women aged 50-59 - 16 seconds ago
- Spironolactone and Cad for Women aged 50-59 - 16 seconds ago